COO and Executive Director

Company Secretary

Clarity Pharmaceuticals Locks in Copper-67 Supply from Nusano

Clarity signs copper-67 Supply Agreement with Nusano

Co-PSMA trial achieves primary endpoint

Lantheus hands GE HealthCare the rights to its blockbuster prostate cancer PET tracer in Japan

Quality Lead

Clarity Pharmaceuticals is a leading radiopharmaceutical company focused on developing Targeted Copper Theragnostic (TCT’s) for serious diseases. The Quality Lead will manage external suppliers to ensure compliance with GMP/GLP requirements, lead technical evaluations, and support the Quality Management System for radiopharmaceutical manufacturing and testing.

Sign up with Google

Sign in with Google